Parametric Portfolio Associates’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $409K | Buy |
7,121
+5,442
| +324% | +$313K | ﹤0.01% | 3179 |
|
|
2021
Q4 | $199K | Sell |
1,679
-125
| -7% | -$14.8K | ﹤0.01% | 3429 |
|
|
2021
Q3 | $359K | Buy |
1,804
+478
| +36% | +$95.1K | ﹤0.01% | 3230 |
|
|
2021
Q2 | $231K | Buy |
1,326
+262
| +25% | +$45.6K | ﹤0.01% | 3351 |
|
|
2021
Q1 | $211K | Buy |
1,064
+6
| +0.6% | +$1.19K | ﹤0.01% | 3860 |
|
|
2020
Q4 | $208K | Buy |
1,058
+48
| +5% | +$9.44K | ﹤0.01% | 3756 |
|
|
2020
Q3 | $179K | Sell |
1,010
-195
| -16% | -$34.6K | ﹤0.01% | 3691 |
|
|
2020
Q2 | $279K | Buy |
+1,205
| New | +$279K | ﹤0.01% | 3504 |
|
|
2019
Q2 | – | Sell |
-450
| Closed | -$91K | – | 4000 |
|
|
2019
Q1 | $91K | Buy |
+450
| New | +$91K | ﹤0.01% | 3828 |
|